Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986279 · ClinicalTrials.gov registry record · NA
Improving Psychological and Vestibular Health: MINDGAPS
A NA study of Vestibular Hypofunction, sponsored by University of Montana.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT05986279: Recruiting NA study of Vestibular Hypofunction, sponsored by University of Montana.
NCT05986279 is a NA study of Vestibular Hypofunction that is actively recruiting participants, run by University of Montana. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05986279, a NA study of Vestibular Hypofunction, is actively recruiting participants, sponsored by University of Montana.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is twofold: 1) Develop norms for measures of inner ear function and psychological health, and 2) Examine the feasibility of using the MINDGAPS system (a remote monitoring system) to track progress during physical therapy or rehabilitation for inner ear problems following a concussion or mild Traumatic Brain Injury.
Primary Outcome
computerized measure of functional gaze stability
Conditions Studied
Interventions
- OTHER Rehab
Study Locations (2)
California
- Naval Medical Center San Diego - San Diego
Montana
- University of Montana - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2027-09-29 |
| Phase | NA |
What NCT05986279 shows while recruiting
NCT05986279 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Vestibular Hypofunction appearing as the primary indexed condition, and to 1 intervention - of which Rehab is the first listed.
NCT05986279 reports a single indexed study location in California, Montana.
Frequently Asked Questions
What is clinical trial NCT05986279 about?
NCT05986279 is a clinical study titled "Improving Psychological and Vestibular Health: MINDGAPS". The purpose of this study is twofold: 1) Develop norms for measures of inner ear function and psychological health, and 2) Examine the feasibility of using the MINDGAPS system (a remote monitoring system) to track progress during physical therapy or rehabilitation for inner ear problems following a ...
What is the current status of trial NCT05986279?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-08-30. Estimated completion is 2027-09-29.
What conditions does trial NCT05986279 study?
This clinical trial studies the following conditions: Vestibular Hypofunction.
What interventions are being tested in trial NCT05986279?
The interventions under investigation include: Rehab (OTHER).
Who is sponsoring clinical trial NCT05986279?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986279 being conducted?
This trial has 2 study locations across California, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Hypofunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05986279's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI